Please use this identifier to cite or link to this item:
|Title:||Differential efficacy of three cycles of CMF followed by tamoxifen in patients with ER-positive and ER-negative tumors: Long-term follow up on IBCSG Trial IX.|
Gusterson, B. A.
Price, K. N.
Regan, Meredith M.
School of Public Health: Public Health
|Publisher:||Oxford University Press|
|Citation:||Differential efficacy of three cycles of CMF followed by tamoxifen in patients with ER-positive and ER-negative tumors: Long-term follow up on IBCSG Trial IX., Annals of Oncology, vol.22, 9, 2011,pp 1981-1987|
|Department/Unit/Centre:||School of Public Health: Public Health|
|Disclaimer:||This work has been made available to the staff and students of the University of Sydney for the purposes of research and study only. It constitutes material that is held by the University for the purposes of reporting for HERDC and the ERA. This work may not be downloaded, copied and distributed to any third party .|
|Type:||C1 - Refereed Journal articles|
|Appears in Collections:||University of Sydney Research Outputs|
Items in Sydney Research Online are protected by copyright, with all rights reserved, unless otherwise indicated.